米国の人工内耳市場規模、シェア、動向分析レポート：年齢層別、最終用途別、地域別、セグメント別予測、2024年～2030年

米国の人工内耳市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、米国の人工内耳市場規模は2030年までに9億4,010万米ドルに達し、2024年から2030年までのCAGRは6.08％で成長すると予測されています。

米国における聴覚障害者の数と加齢による難聴の有病率の増加が、米国市場における人工内耳の需要を促進しています。

米国国立聴覚障害研究所（NIDCD）によると、米国では1000人の子供のうち2～3人が識別可能な難聴を患っており、また、米国ではおよそ1000人の乳児のうち1人が感音性一側性難聴に罹患しているとしています。米国食品医薬品局（FDA）は2019年、こうした患者を救うため、5歳以上の片耳難聴（SSD）の子どもに対する人工内耳埋め込みを認可しました。

難聴と人工内耳の利点についての認識を高めることにより、これらの組織は需要を増加させ、技術のより良い理解を促進し、市場の成長を促進するであろう。米国における人工内耳の適用範囲拡大など、聴覚障害者の治療価値や差別問題に焦点を当てた政府の取り組みは、市場拡大を促進します。

米国人工内耳市場のレポートハイライト：

• 年齢層別では、難聴の有病率の上昇により、成人向けが2023年に64.2%以上の最大市場シェアを占めました。小児セグメントは2024年から2030年にかけて最も速いCAGRで成長する見込み。
• 最終用途に基づくと、診療所セグメントは2023年に最大の収益シェアを占めました。クリニック、特に耳鼻咽喉科クリニックは、人工内耳の候補者の評価、手術の実施、術後のケアなどの専門知識を提供する、人工内耳サービスの不可欠なプロバイダーです。
• 診断率の上昇、聴覚障害に対する意識の高まり、両耳装用への要望の高まり、政府による支援プログラムなどが、この成長を促進する要因として期待されています。
• 2021年6月、オーティコン・メディカル社は、18歳以上の両側性の高度～高度感音難聴者向けの製品であるニューロシステムが米国食品医薬品局（FDA）から市販前承認（PMA）を取得したと発表しました。これらの人々は、人工内耳製品と一緒に米国市場に参入することで、ウェアラブル技術の恩恵を限定的に受けることになります。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国の人工内耳市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場牽引要因分析
  • 市場抑制要因分析
• 米国人工内耳市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 米国の人工内耳市場：年齢層の推定・動向分析

• 年齢グループ別市場シェア、2023年および2030年
• セグメントダッシュボード
• 米国の人工内耳市場の年齢別展望
• 2018年から2030年までの市場規模と予測および動向分析
• 成人
• 小児

第5章 米国の人工内耳市場：最終用途の推定・動向分析

• 最終用途市場シェア、2023年および2030年
• セグメントダッシュボード
• 米国の人工内耳市場の用途別展望
• 2018年から2030年までの市場規模と予測および動向分析
• 病院
• クリニック
• その他

第6章 米国の人工内耳市場：地域の推定・動向分析

• 地域別市場シェア、2023年および2030年
• 地域別米国人工内耳市場の見通し
• 2018年から2030年までの市場規模と予測および動向分析
• 西部
• 中西部
• 北東部
• 南西部
• 南東部

第7章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
• ベンダー情勢
• 企業プロファイル
  • Cochlear Ltd
  • MED-EL Medical Electronics
  • Oticon Medical
  • Advanced Bionics Corporation
  • Sonova Holding AG
  • Medtronic
  • Nurotron Biotechnology Co., Ltd
  • ZPower, LLC
  • Widex A/S

List of Tables

• Table 1 List of abbreviations
• Table 2 List of Secondary Sources
• Table 3 U.S. Cochlear Implants Market, By Age group, 2018 - 2030 (USD Million)
• Table 4 U.S. Cochlear Implants Market, By End-use, 2018 - 2030 (USD Million)
• Table 5 U.S. Cochlear Implants Market, By Region, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 U.S. Cochlear Implants market: market outlook
• Fig. 9 U.S. Cochlear Implants competitive insights
• Fig. 10 Parent market outlook
• Fig. 11 Related/ancillary market outlook
• Fig. 12 Penetration and growth prospect mapping
• Fig. 13 U.S. cochlear implants market driver impact
• Fig. 14 U.S. cochlear implants market restraint impact
• Fig. 15 U.S. cochlear implants market: Age Group movement analysis
• Fig. 16 U.S. cochlear implants market: Age Group outlook and key takeaways
• Fig. 17 Adult market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 18 Pediatric market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 19 Adult unilateral implants market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 20 Adult bilateral implants market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 21 Pediatric unilateral implants market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 22 Pediatric bilateral implants market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 23 U.S. cochlear implants market: End-use movement analysis
• Fig. 24 U.S. cochlear implants market: End-use outlook and key takeaways
• Fig. 25 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 26 Clinics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 27 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 28 U.S. cochlear implants market: regional movement analysis
• Fig. 29 U.S. cochlear implants market: regional outlook and key takeaways
• Fig. 30 West market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 31 Midwest market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 32 Northeast market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 33 Southwest market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Southeast market estimates and forecasts, 2018 - 2030 (USD Million)

U.S. Cochlear Implants Market Growth & Trends:

The U.S. cochlear implants market size is anticipated to reach USD 940.1 million by 2030, growing at CAGR of 6.08% from 2024 to 2030, according to a new report by Grand View Research, Inc. The number of individuals with hearing impairments and the increasing prevalence of age-related hearing loss in the U.S. is driving the demand for cochlear implants in the U.S. market.

According to the National Institute of Deafness and Other Communication Disorders (NIDCD), 2 to 3 out of every 1000 children have hearing loss that can be identified in the U.S. It also stated that roughly 1 in 1000 live infants are affected by sensorineural unilateral hearing loss in the country. The U.S. Food and Drug Administration (FDA) authorized cochlear implantation in 2019 for children with single-sided deafness (SSD) who were five years or older to help these patients.

By raising awareness about hearing loss and the benefits of cochlear implants, these organizations increase demand and promote a better understanding of the technology, which would drive the market's growth. Government initiatives focusing on therapeutic value and discriminatory issues spurred by people with impairments, such as expanded coverage for cochlear implants in the U.S. promote market expansion.

U.S. Cochlear Implants Market Report Highlights:

• Based on age group, the adult segment held the largest market share of over 64.2% in 2023 owing to the rising prevalence of hearing loss. The pediatric segment is expected to grow at the fastest CAGR from 2024 to 2030
• Based on end-use, the clinics segment accounted for the largest revenue share in 2023. Clinics, particularly ENT clinics, are essential providers of cochlear implant services, offering expertise in evaluating candidates for implants, conducting surgeries, and providing post-operative care
• The rising diagnosis rates, growing awareness of hearing impairment, growing desire for bilateral fittings, and supportive government programs are some factors expected to drive this growth.
• In June 2021, Oticon Medical announced that the Neuro System, the company's product for treating individuals 18 years of age or older with bilateral severe-to-profound sensorineural hearing loss, has received premarket approval (PMA) from the U.S. Food and Drug Administration (FDA). These individuals stand to benefit limitedly from wearable technology, by entering the U.S. market with its cochlear implant products.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Age Group
  • 1.2.2. End-use
  • 1.2.3. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Volume price analysis (Model 2)
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Age Group outlook
  • 2.2.2. End-use outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Cochlear Implants Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. U.S. Cochlear Implants Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. U.S. Cochlear Implants Market: Age Group Estimates & Trend Analysis

• 4.1. Age Group Market Share, 2023 & 2030
• 4.2. Segment Dashboard
• 4.3. U.S. Cochlear Implants Market by Age Group Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Adult
  • 4.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
• 4.6. Pediatric
  • 4.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (USD Million)
  • 4.6.2. Adult Unilateral Implants
    • 4.6.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.6.3. Adult Bilateral Implants
    • 4.6.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (USD Million)
  • 4.6.4. Pediatric Unilateral Implants
    • 4.6.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.6.5. Pediatric Bilateral Implants
    • 4.6.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (USD Million)

Chapter 5. U.S. Cochlear Implants Market: End-use Estimates & Trend Analysis

• 5.1. End-use Market Share, 2023 & 2030
• 5.2. Segment Dashboard
• 5.3. U.S. Cochlear Implants Market by Application Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.4.1. Hospitals
    • 5.4.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.4.2. Clinics
    • 5.4.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.4.3. Others
    • 5.4.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6. U.S. Cochlear Implants Market: Region Estimates & Trend Analysis

• 6.1. Regional Market Share, 2023 & 2030
• 6.2. U.S. Cochlear Implants Market by Region Outlook
• 6.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
  • 6.3.1. West
    • 6.3.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
  • 6.3.2. Midwest
    • 6.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.3.3. Northeast
    • 6.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.3.4. Southwest
    • 6.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.3.5. Southeast
    • 6.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Vendor Landscape
  • 7.3.1. List of key distributors and channel partners
  • 7.3.2. Key customers
  • 7.3.3. Key company heat map analysis, 2023
• 7.4. Company Profiles
  • 7.4.1. Cochlear Ltd
    • 7.4.1.1. Company overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Product benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. MED-EL Medical Electronics
    • 7.4.2.1. Company overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Product benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. Oticon Medical
    • 7.4.3.1. Company overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Product benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. Advanced Bionics Corporation
    • 7.4.4.1. Company overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Product benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. Sonova Holding AG
    • 7.4.5.1. Company overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Product benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. Medtronic
    • 7.4.6.1. Company overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Product benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. Nurotron Biotechnology Co., Ltd
    • 7.4.7.1. Company overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Product benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. ZPower, LLC
    • 7.4.8.1. Company overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Product benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. Widex A/S
    • 7.4.9.1. Company overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Product benchmarking
    • 7.4.9.4. Strategic initiatives